EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.9773
March 31, 2026 -6.665
December 31, 2025 -23.59
September 30, 2025 -19.05
June 30, 2025 -16.78
March 31, 2025 -28.55
December 31, 2024 -251.11
September 30, 2024 -2.095
June 30, 2024 -3.719
March 31, 2024 -6.356
December 31, 2023 -6.764
September 30, 2023 -4.658
June 30, 2023 -7.712
March 31, 2023 -5.416
Date Value
December 31, 2022 -4.839
September 30, 2022 -6.973
June 30, 2022 -5.91
March 31, 2022 -5.439
December 31, 2021 -4.695
September 30, 2021 -4.459
June 30, 2021 -4.249
March 31, 2021 -11.61
December 31, 2020 -4.854
September 30, 2020 -3.796
June 30, 2020 -0.5304
March 31, 2020 -4.796
December 31, 2019 -4.109
September 30, 2019 -6.415

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.0004
SCWorx Corp. -1.355
Health Catalyst, Inc. -0.5481
GoodRx Holdings, Inc. 0.0245
Claritev Corp. -3.491